Moleculin Biotech loss $5.0 millionChristian Fernsby ▼ | August 13, 2020
Moleculin Biotech announced its financial results for the quarter ended June 30, 2020.
Moleculin Biotech Loss from operations quarter was $5.0 million
Topics: Moleculin Biotech
Net loss for the second quarter of 2020 was $10.1 million, compared to a net loss of $1.2 million in the second quarter of 2019. ■